268 related articles for article (PubMed ID: 17974958)
1. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
Iwata C; Kano MR; Komuro A; Oka M; Kiyono K; Johansson E; Morishita Y; Yashiro M; Hirakawa K; Kaminishi M; Miyazono K
Cancer Res; 2007 Nov; 67(21):10181-9. PubMed ID: 17974958
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C.
Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
Anat Rec (Hoboken); 2009 Oct; 292(10):1577-83. PubMed ID: 19685508
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
[TBL] [Abstract][Full Text] [Related]
4. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer.
Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
Anat Rec (Hoboken); 2010 Nov; 293(11):1838-46. PubMed ID: 20830783
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
Morita Y; Hata K; Nakanishi M; Nishisho T; Yura Y; Yoneda T
Int J Oncol; 2012 Sep; 41(3):885-92. PubMed ID: 22735610
[TBL] [Abstract][Full Text] [Related]
6. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
7. [COX- 2 expression in gastric cancer and its relationship with lymphangiogenesis and lymph node metastasis].
Zhang J; Ji J; Yuan F; Yan C; Yu YY; Liu BY; Zhu ZG; Yin HR; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jul; 8(4):348-51. PubMed ID: 16167260
[TBL] [Abstract][Full Text] [Related]
8. [The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities].
Wang KF; Ye SL; Song LJ; Weng YQ; Liang CM; Zhao Y; Gao DM; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):187-91. PubMed ID: 16556412
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
Yanai Y; Furuhata T; Kimura Y; Yamaguchi K; Yasoshima T; Mitaka T; Mochizuki Y; Hirata K
J Exp Clin Cancer Res; 2001 Sep; 20(3):419-28. PubMed ID: 11718224
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
Kawakami M; Yanai Y; Hata F; Hirata K
Surg Today; 2005; 35(2):131-8. PubMed ID: 15674494
[TBL] [Abstract][Full Text] [Related]
12. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
13. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y
Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.
Sipos B; Kojima M; Tiemann K; Klapper W; Kruse ML; Kalthoff H; Schniewind B; Tepel J; Weich H; Kerjaschki D; Klöppel G
J Pathol; 2005 Nov; 207(3):301-12. PubMed ID: 16161179
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer.
Da MX; Wu XT; Wang J; Guo TK; Zhao ZG; Luo T; Zhang MM; Qian K
Arch Med Res; 2008 Jan; 39(1):92-9. PubMed ID: 18068001
[TBL] [Abstract][Full Text] [Related]
16. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
[TBL] [Abstract][Full Text] [Related]
17. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
18. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
[TBL] [Abstract][Full Text] [Related]
19. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
He XW; Yu X; Liu T; Yu SY; Chen DJ
Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.
Chen Z; Varney ML; Backora MW; Cowan K; Solheim JC; Talmadge JE; Singh RK
Cancer Res; 2005 Oct; 65(19):9004-11. PubMed ID: 16204074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]